{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:26:23Z","timestamp":1778135183851,"version":"3.51.4"},"posted":{"date-parts":[[2023,10,16]]},"group-title":"In Review","reference-count":50,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,10,2]]},"abstract":"<title>Abstract<\/title>\n        <p>The pathogenesis of primary sclerosing cholangitis (PSC) is unclear, although studies implicate IL-17A as an inflammatory mediator in this disease. However, a direct assessment of IL-17 signaling in PSC cholangiocytes is lacking. In this study we aimed to investigate the response of PSC extrahepatic cholangiocyte organoids (ECO) to IL-17A stimulation. Cholangiocytes obtained from PSC and non-PSC patients by endoscopic retrograde cholangiography (ERC) were cultured as ECO. The ECO were treated with vehicle or IL-17A and assessed by transcriptomics, secretome analysis, and genome sequencing (GS). Unsupervised clustering of all integrated scRNA-seq data identified 8 cholangiocyte clusters which did not differ between PSC and non-PSC ECO. However, PSC ECO cells demonstrated a robust response to IL-17 treatment, noted by an increased number of differentially expressed genes (DEG) by transcriptomics, and more abundant chemokine and cytokine expression and secretion. After rigorous filtering, GS identified candidate somatic variants shared among PSC ECO from unrelated individuals. However, no candidate rare variants in genes regulating the IL-17 pathway were identified, but rare variants regulating the MAPK signaling pathway were present in all PSC ECO. In conclusion, PSC and non-PSC patient derived ECO respond differently to IL-17 stimulation implicating this pathway in the pathogenesis of PSC.<\/p>","DOI":"10.21203\/rs.3.rs-3406046\/v1","type":"posted-content","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T18:03:27Z","timestamp":1697479407000},"source":"Crossref","is-referenced-by-count":2,"title":["IL-17 Signaling in Primary Sclerosing Cholangitis Patient-Derived Organoids"],"prefix":"10.21203","author":[{"given":"Ana Sofia Garcia","family":"Moreno","sequence":"first","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Eugenia","family":"Guicciardi","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Q.","family":"Wixom","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Jessen","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingchun","family":"Yang","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumera I.","family":"Ilyas","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie K.","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo Pinto e","family":"Vairo","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos N.","family":"Lazaridis","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Gores","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary Sclerosing Cholangitis","volume":"375","author":"Lazaridis KN","year":"2016","unstructured":"Lazaridis KN, LaRusso NF. Primary Sclerosing Cholangitis. N Engl J Med 375, 1161\u20131170 (2016).","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.30470","article-title":"Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile","volume":"70","author":"Soroka CJ,","year":"2019","unstructured":"Soroka CJ, et al. Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile. Hepatology 70, 871\u2013882 (2019).","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","article-title":"Characterization of animal models for primary sclerosing cholangitis (PSC)","volume":"60","author":"Fickert P,","year":"2014","unstructured":"Fickert P, et al. Characterization of animal models for primary sclerosing cholangitis (PSC). J Hepatol 60, 1290\u20131303 (2014).","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1136\/gutjnl-2019-319256","article-title":"Liver organoids: from basic research to therapeutic applications","volume":"68","author":"Prior N","year":"2019","unstructured":"Prior N, Inacio P, Huch M. Liver organoids: from basic research to therapeutic applications. Gut 68, 2228\u20132237 (2019).","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.stem.2021.04.005","article-title":"Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids","volume":"28","author":"Marsee A,","year":"2021","unstructured":"Marsee A, et al. Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell Stem Cell 28, 816\u2013832 (2021).","journal-title":"Cell Stem Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"630492","DOI":"10.3389\/fcell.2020.630492","article-title":"Human Bile Contains Cholangiocyte Organoid-Initiating Cells Which Expand as Functional Cholangiocytes in Non-canonical Wnt Stimulating Conditions","volume":"8","author":"Roos FJM,","year":"2020","unstructured":"Roos FJM, et al. Human Bile Contains Cholangiocyte Organoid-Initiating Cells Which Expand as Functional Cholangiocytes in Non-canonical Wnt Stimulating Conditions. Front Cell Dev Biol 8, 630492 (2020).","journal-title":"Front Cell Dev Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41596-019-0168-0","article-title":"Isolation and propagation of primary human cholangiocyte organoids for the generation of bioengineered biliary tissue","volume":"14","author":"Tysoe OC,","year":"2019","unstructured":"Tysoe OC, et al. Isolation and propagation of primary human cholangiocyte organoids for the generation of bioengineered biliary tissue. Nat Protoc 14, 1884\u20131925 (2019).","journal-title":"Nat Protoc"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/bit.27613","article-title":"Scaffolds obtained from decellularized human extrahepatic bile ducts support organoids to establish functional biliary tissue in a dish","volume":"118","author":"Willemse J,","year":"2021","unstructured":"Willemse J, et al. Scaffolds obtained from decellularized human extrahepatic bile ducts support organoids to establish functional biliary tissue in a dish. Biotechnol Bioeng 118, 836\u2013851 (2021).","journal-title":"Biotechnol Bioeng"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.31252","article-title":"Regional Differences in Human Biliary Tissues and Corresponding In Vitro-Derived Organoids","volume":"73","author":"Rimland CA,","year":"2021","unstructured":"Rimland CA, et al. Regional Differences in Human Biliary Tissues and Corresponding In Vitro-Derived Organoids. Hepatology 73, 247\u2013267 (2021).","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"21900","DOI":"10.1038\/s41598-020-79082-8","article-title":"Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease","volume":"10","author":"Verstegen MMA,","year":"2020","unstructured":"Verstegen MMA, et al. Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease. Sci Rep 10, 21900 (2020).","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1512711","article-title":"Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis","volume":"375","author":"Gordon KB,","year":"2016","unstructured":"Gordon KB, et al. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. N Engl J Med 375, 345\u2013356 (2016).","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis","volume":"373","author":"Baeten D,","year":"2015","unstructured":"Baeten D, et al. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med 373, 2534\u20132548 (2015).","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor-based signaling and implications for disease","volume":"20","author":"Li X","year":"2019","unstructured":"Li X, Bechara R, Zhao J, McGeachy MJ, Gaffen SL. IL-17 receptor-based signaling and implications for disease. Nat Immunol 20, 1594\u20131602 (2019).","journal-title":"Nat Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen SL","year":"2009","unstructured":"Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9, 556\u2013567 (2009).","journal-title":"Nat Rev Immunol"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028522","article-title":"Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications","volume":"10","author":"Monin L","year":"2018","unstructured":"Monin L, Gaffen SL. Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications. Cold Spring Harb Perspect Biol 10, (2018).","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park H,","year":"2005","unstructured":"Park H, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6, 1133\u20131141 (2005).","journal-title":"Nat Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.4049\/jimmunol.1203218","article-title":"IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells","volume":"190","author":"Tang XZ","year":"2013","unstructured":"Tang XZ, et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol 190, 3142\u20133152 (2013).","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/infdis\/jis018","article-title":"Differential antigen specificity of hepatitis C virus-specific interleukin 17- and interferon \u03b3-producing CD8(+) T cells during chronic infection","volume":"205","author":"Grafmueller S","year":"2012","unstructured":"Grafmueller S, Billerbeck E, Blum HE, Neumann-Haefelin C, Thimme R. Differential antigen specificity of hepatitis C virus-specific interleukin 17- and interferon \u03b3-producing CD8(+) T cells during chronic infection. J Infect Dis 205, 1142\u20131146 (2012).","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua DJ","year":"2010","unstructured":"Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10, 479\u2013489 (2010).","journal-title":"Nat Rev Immunol"},{"key":"ref20","author":"Hammerich L","year":"2011","unstructured":"Hammerich L, Heymann F, Tacke F. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol 2011, 345803 (2011)."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26447","article-title":"Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis","volume":"58","author":"Katt J,","year":"2013","unstructured":"Katt J, et al. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis. Hepatology 58, 1084\u20131093 (2013).","journal-title":"Hepatology"},{"key":"ref22","author":"Kunzmann LK,","year":"2020","unstructured":"Kunzmann LK, et al. Monocytes as potential mediators of pathogen-induced Th17 differentiation in patients with primary sclerosing cholangitis (PSC). Hepatology, (2020)."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5604\/16652681.1198820","article-title":"Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-\u03b22 expression","volume":"15","author":"Zepeda-Morales AS","year":"2016","unstructured":"Zepeda-Morales AS, et al. Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-\u03b22 expression. Ann Hepatol 15, 418\u2013426 (2016).","journal-title":"Ann Hepatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng F,","year":"2012","unstructured":"Meng F, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143, 765\u2013776.e763 (2012).","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9922","DOI":"10.18632\/oncotarget.14266","article-title":"Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10\/STAT3-suppressed autophagy in hepatocytes","volume":"8","author":"Zhang XW,","year":"2017","unstructured":"Zhang XW, et al. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10\/STAT3-suppressed autophagy in hepatocytes. Oncotarget 8, 9922\u20139934 (2017).","journal-title":"Oncotarget"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1053\/j.gastro.2018.02.019","article-title":"Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic \u03b3\u03b4 T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease","volume":"154","author":"Tedesco D,","year":"2018","unstructured":"Tedesco D, et al. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic \u03b3\u03b4 T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease. Gastroenterology 154, 2178\u20132193 (2018).","journal-title":"Gastroenterology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ajpath.2013.07.019","article-title":"IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis","volume":"183","author":"O'Brien KM","year":"2013","unstructured":"O'Brien KM, Allen KM, Rockwell CE, Towery K, Luyendyk JP, Copple BL. IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis. Am J Pathol 183, 1498\u20131507 (2013).","journal-title":"Am J Pathol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jss.2013.03.025","article-title":"Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice","volume":"183","author":"Hara M","year":"2013","unstructured":"Hara M, Kono H, Furuya S, Hirayama K, Tsuchiya M, Fujii H. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. J Surg Res 183, 574\u2013582 (2013).","journal-title":"J Surg Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jhep.2020.10.035","article-title":"IL-17A\/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression","volume":"74","author":"Stein S,","year":"2021","unstructured":"Stein S, et al. IL-17A\/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression. J Hepatol 74, 919\u2013930 (2021).","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/s41591-023-02372-x","article-title":"Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis","volume":"29","author":"Shaw DG,","year":"2023","unstructured":"Shaw DG, et al. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nat Med 29, 1520\u20131529 (2023).","journal-title":"Nat Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1844-5","article-title":"Somatic inflammatory gene mutations in human ulcerative colitis epithelium","volume":"577","author":"Nanki K,","year":"2020","unstructured":"Nanki K, et al. Somatic inflammatory gene mutations in human ulcerative colitis epithelium. Nature 577, 254\u2013259 (2020).","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.bbadis.2017.06.024","article-title":"Pathobiology of biliary epithelia","volume":"1864","author":"Cheung AC","year":"2018","unstructured":"Cheung AC, Lorenzo Pisarello MJ, LaRusso NF. Pathobiology of biliary epithelia. Biochim Biophys Acta Mol Basis Dis 1864, 1220\u20131231 (2018).","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nature01627","article-title":"Humanin peptide suppresses apoptosis by interfering with Bax activation","volume":"423","author":"Guo B,","year":"2003","unstructured":"Guo B, et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423, 456\u2013461 (2003).","journal-title":"Nature"},{"key":"ref34","first-page":"D886-D894","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"Rentzsch P","year":"2018","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Research 47, D886-D894 (2018).","journal-title":"Nucleic Acids Research"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"D587-d592","DOI":"10.1093\/nar\/gkac963","article-title":"KEGG for taxonomy-based analysis of pathways and genomes","volume":"51","author":"Kanehisa M","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res 51, D587-d592 (2023).","journal-title":"Nucleic Acids Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41467-022-34606-w","article-title":"Unique DUOX2(+)ACE2(+) small cholangiocytes are pathogenic targets for primary biliary cholangitis","volume":"14","author":"Li X","year":"2023","unstructured":"Li X, et al. Unique DUOX2(+)ACE2(+) small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nat Commun 14, 29 (2023).","journal-title":"Nat Commun"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.4049\/jimmunol.177.6.4064","article-title":"IL-17A induces eotaxin-1\/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1\/2, JNK, and p38) pathways","volume":"177","author":"Rahman MS","year":"2006","unstructured":"Rahman MS, Yamasaki A, Yang J, Shan L, Halayko AJ, Gounni AS. IL-17A induces eotaxin-1\/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1\/2, JNK, and p38) pathways. J Immunol 177, 4064\u20134071 (2006).","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus CL,","year":"2023","unstructured":"Bowlus CL, et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 77, 659\u2013702 (2023).","journal-title":"Hepatology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1002\/cpcb.82","article-title":"Generation of Pancreatic Ductal Organoids and Whole-Mount Immunostaining of Intact Organoids","volume":"83","author":"Rezanejad H","year":"2019","unstructured":"Rezanejad H, Lock JH, Sullivan BA, Bonner-Weir S. Generation of Pancreatic Ductal Organoids and Whole-Mount Immunostaining of Intact Organoids. Curr Protoc Cell Biol 83, e82 (2019).","journal-title":"Curr Protoc Cell Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng GX,","year":"2017","unstructured":"Zheng GX, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun 8, 14049 (2017).","journal-title":"Nat Commun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao Y,","year":"2021","unstructured":"Hao Y, et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky I,","year":"2019","unstructured":"Korsunsky I, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16, 1289\u20131296 (2019).","journal-title":"Nat Methods"},{"key":"ref43","author":"Auwera GA","year":"2020","unstructured":"Van der Auwera GA & O'Connor BD. (2020). Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (1st Edition). O'Reilly Media."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim S,","year":"2018","unstructured":"Kim S, et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods 15, 591\u2013594 (2018).","journal-title":"Nat Methods"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/bioinformatics\/btu137","article-title":"The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation","volume":"30","author":"Kocher J-PA","year":"2014","unstructured":"Kocher J-PA, et al. The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation. Bioinformatics 30, 1920\u20131922 (2014).","journal-title":"Bioinformatics"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13073-015-0195-6","article-title":"CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting","volume":"7","author":"M\u00fcnz M,","year":"2015","unstructured":"M\u00fcnz M, et al. CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting. Genome Medicine 7, 76 (2015).","journal-title":"Genome Medicine"},{"key":"ref47","first-page":"D941-D947","article-title":"The International Genome Sample Resource (IGSR) collection of open human genomic variation resources","volume":"48","author":"Fairley S","year":"2019","unstructured":"Fairley S, Lowy-Gallego E, Perry E, Flicek P. The International Genome Sample Resource (IGSR) collection of open human genomic variation resources. Nucleic Acids Research 48, D941-D947 (2019).","journal-title":"Nucleic Acids Research"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek M,","year":"2016","unstructured":"Lek M, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"ref49","author":"Chen S,","year":"2022","unstructured":"Chen S, et al. A genome-wide mutational constraint map quantified from variation in 76,156 human genomes.). bioRxiv (2022)."},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon P,","year":"2003","unstructured":"Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498\u20132504 (2003).","journal-title":"Genome Res"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3406046\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3406046\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T05:15:39Z","timestamp":1707455739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3406046\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":50,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3406046\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,10,16]]},"subtype":"preprint"}}